Characterization of Ustekinumab-Associated Infections in Patients with moderate to severe Plaque-Psoriasis

被引:0
|
作者
Leonardi, C. [1 ]
Guenther, L. [2 ]
Wasel, N. [3 ]
Yeilding, N. [4 ]
Szapary, P. O. [4 ]
Hsu, M-C [4 ]
Reich, K. [5 ]
机构
[1] Dept Dermatol, St Louis, MO USA
[2] Guenther Dermatol Res Ctr, London, ON, Canada
[3] Strat Med, Edmonton, AB, Canada
[4] Centocor Res & Dev, Malvern, PA USA
[5] SCIderm GmbH, Hamburg, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:194 / 195
页数:2
相关论文
共 50 条
  • [31] COST UTILITY ANALYSIS OF USTEKINUMAB FOR THE TREATMENT OF MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS IN THAILAND
    Tangwongsiri, D.
    Leartsakulpanitch, J.
    VALUE IN HEALTH, 2014, 17 (07) : A782 - A783
  • [32] Patient reported health outcomes and non-adherence in psoriasis patients receiving adalimumab or ustekinumab for moderate to severe plaque psoriasis
    Goren, Amir
    Carter, Chureen
    Lee, Seina
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (01) : 43 - 50
  • [33] BUDGET IMPACT ANALYSIS OF USTEKINUMAB FOR THE TREATMENT OF MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS IN THAILAND
    Tangwongsiri, D.
    Leartsakulpanitch, J.
    VALUE IN HEALTH, 2012, 15 (07) : A679 - A679
  • [34] COST-EFFECTIVENESS OF USTEKINUMAB IN THE MANAGEMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN MEXICO
    Valencia-Mendoza, A.
    Hernandez-Garduno, A.
    Puig, A.
    VALUE IN HEALTH, 2012, 15 (07) : A513 - A514
  • [35] Polymorphisms Associated with Age at Onset in Patients with Moderate-to-Severe Plaque Psoriasis
    Prieto-Perez, Rocio
    Solano-Lopez, Guillermo
    Cabaleiro, Teresa
    Roman, Manuel
    Ochoa, Dolores
    Talegon, Maria
    Baniandres, Ofelia
    Luis Lopez-Estebaranz, Jose
    de la Cueva, Pablo
    Dauden, Esteban
    Abad-Santos, Francisco
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [36] Sustained long-term Efficacy of Ustekinumab over 3 Years in Patients with moderate to severe Plaque Psoriasis
    Ghislain, P-D
    Poulin, Y.
    Wasel, N.
    Menter, A.
    Sofen, H.
    Yeilding, N.
    Fakharzadeh, S.
    Li, S.
    Leonardi, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 195 - 195
  • [37] Treatment of plaque-psoriasis in HIV-positive patients
    Jugovac, Vita
    Gulin, Marija
    Baric, Dora
    Drvar, Daniela Ledic
    Ceovic, Romana
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2024, 33 (01): : 37 - 40
  • [38] Experience of pain in patients with moderate to severe plaque psoriasis
    Revicki, Dennis
    Wilson, Hilary D.
    Pinto, Lionel A.
    Viswanathan, Hema
    QUALITY OF LIFE RESEARCH, 2014, 23 : 102 - 102
  • [39] Racial/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque-psoriasis: A systematic review
    Ferguson, Jessica Elizabeth
    Seger, Edward W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB5 - AB5
  • [40] INCIDENCE OF INFECTIONS IN CLINICAL TRIALS OF TILDRAKIZUMAB FOR MODERATE TO SEVERE PLAQUE PSORIASIS
    Crowley, Jeffrey
    Leonardi, Craig
    Sturgill-Koszycki, Sheila
    Menter, Alan
    Mendelsohn, Alan
    Li, Qing
    Cichanowitz, Nicole
    La Rosa, Carmen
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 28 - 28